Track Cell Impact AB (publ)'s receivables ($700K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest receivables for CI-B.ST is $700K as of September 2026. That compares with $15M in the prior-year period — down 95.2% year over year. Investors often review this figure alongside Cell Impact AB (publ)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, CI-B.ST's receivables moved from $15M to $700K — a 95.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cell Impact AB (publ)'s operating scale or balance-sheet position.
A receivables figure of $700K for CI-B.ST is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting CI-B.ST's receivables ($700K), review year-over-year change from $15M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.